Thanks Cosmoterios , it is a must read , Biotech investors will...

Thanks Cosmoterios , it is a must read , Biotech investors will be mad not to get in at this level or sell RHT shares now, market is huge in the US alone, world wide its mega , the cash is just starting roll in, RHT is already cash flow positive , not hard to see a $20 million profit in the next 12 months , a PE of 10 gives a market cap of at least $200 million , 5 x share price from here , sellers are making a big mistake .

Across the United States, millions of people of all ages suffer from this silent killer that slowly morphs from nonalcoholic fatty liver disease, a condition that now affects 89 million in the U.S., according to the Center for Disease Analysis. The National Institutes of Health estimates as many as 30 million people, or 12 percent of U.S. adults, now have NASH.